Diagnostic delay of sarcoidosis: Protocol for an integrated systematic review.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
26
05
2022
accepted:
01
11
2022
entrez:
22
2
2023
pubmed:
23
2
2023
medline:
25
2
2023
Statut:
epublish
Résumé
Sarcoidosis is a rare systemic inflammatory granulomatous disease of unknown cause. It can manifest in any organ. The incidence of sarcoidosis varies across countries, and by ethnicity and gender. Delays in the diagnosis of sarcoidosis can lead to extension of the disease and organ impairment. Diagnosis delay is attributed in part to the lack of a single diagnostic test or unified commonly used diagnostic criteria, and to the diversity of disease manifestations and symptom load. There is a paucity of evidence examining the determinants of diagnostic delay in sarcoidosis and the experiences of people with sarcoidosis related to delayed diagnosis. We aim to systematically review available evidence about diagnostic delay in sarcoidosis to elucidate the factors associated with diagnostic delay for this disease in different contexts and settings, and the consequences for people with sarcoidosis. A systematic search of the literature will be conducted using PubMed/Medline, Scopus, and ProQuest databases, and sources of grey literature, up to 25th of May 2022, with no limitations on publication date. We will include all study types (qualitative, quantitative, and mixed methods) except review articles, examining diagnostic delay, incorrect diagnosis, missed diagnosis or slow diagnosis of all types of sarcoidosis across all age groups. We will also examine evidence of patients' experiences associated with diagnostic delay. Only studies in English, German and Indonesian will be included. The outcomes we examine will be diagnostic delay time, patients' experiences, and factors associated with diagnostic delay in sarcoidosis. Two people will independently screen the titles and abstracts of search results, and then the remaining full-text documents against the inclusion criteria. Disagreements will be resolved with a third reviewer until consensus is reached. Selected studies will be appraised using the Mixed Methods Appraisal Tool (MMAT). A meta-analysis and subgroup analyses of quantitative data will be conducted. Meta-aggregation methods will be used to analyse qualitative data. If there is insufficient data for these analyses, a narrative synthesis will be conducted. This review will provide systematic and integrated evidence on the diagnostic delay, associated factors, and experiences of diagnosis delay among people with all types of sarcoidosis. This knowledge may shed light on ways to improve diagnosis delays in diagnosis across different subpopulations, and with different disease presentations. Ethical approval will not be required as no human recruitment or participation will be involved. Findings of the study will be disseminated through publications in peer-reviewed journals, conferences, and symposia. PROSPERO Registration number: CRD42022307236. URL of the PROSPERO registration: https://www.crd.york.ac.uk/PROSPEROFILES/307236_PROTOCOL_20220127.pdf.
Identifiants
pubmed: 36812191
doi: 10.1371/journal.pone.0269762
pii: PONE-D-22-15192
pmc: PMC9946231
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0269762Informations de copyright
Copyright: © 2023 Namsrai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Respir Med. 2020 Jan;161:105846
pubmed: 32056723
Eur Respir J. 2008 Feb;31(2):372-9
pubmed: 17959635
BMC Health Serv Res. 2014 Nov 21;14:579
pubmed: 25413154
Respir Med. 2020 Aug;169:105998
pubmed: 32442109
Chest. 2003 Feb;123(2):406-12
pubmed: 12576358
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Curr Opin Pulm Med. 2009 Sep;15(5):499-506
pubmed: 19458531
Respiration. 2007;74(4):401-5
pubmed: 16612047
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880
J Clin Epidemiol. 2011 Apr;64(4):401-6
pubmed: 21208779
Clin Exp Rheumatol. 2016 May-Jun;34(3):380-8
pubmed: 27050339
Ann Am Thorac Soc. 2016 Aug;13(8):1244-52
pubmed: 27509154
Respir Med. 2021 Oct;187:106548
pubmed: 34352562
Eur Respir J. 2019 Oct 24;54(4):
pubmed: 31391219
Respir Res. 2018 Aug 28;19(1):158
pubmed: 30153830
Eur Respir J. 2016 Dec;48(6):1690-1699
pubmed: 27471207
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):119-27
pubmed: 23461074
Neurologist. 2010 Nov;16(6):386-9
pubmed: 21150390
Neurology. 2009 Oct 6;73(14):1142-8
pubmed: 19805731
Eur J Intern Med. 2021 Sep;91:63-69
pubmed: 34049777
Respir Med. 2018 Nov;144S:S28-S34
pubmed: 29631888
Expert Rev Respir Med. 2022 Jan;16(1):133-143
pubmed: 34402372
Lung. 2017 Feb;195(1):87-91
pubmed: 27709291
Eur Respir J. 1999 Oct;14(4):735-7
pubmed: 10573213